MP
AFJKR

Mangrove Partners’s Aimei Health Technology Co Right AFJKR Stock Holding History

Mangrove Partners’s Portfolio AFJKR Stock Details AFJKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-750,000
Closed -$270K – 155
2025
Q1 		$270K Hold
750,000
– – 0.03% 137
2024
Q4 		$135K Hold
750,000
– – 0.01% 144
2024
Q3 		$173K Hold
750,000
– – 0.01% 142
2024
Q2 		$158K Hold
750,000
– – 0.01% 125
2024
Q1 		$150K Buy
+750,000
New +$148K 0.01% 143

Other funds holding AFJKR

Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
HCI
Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Mangrove Partners's AFJKR Position: Q2 2025 in Review

Mangrove Partners sold out of Aimei Health Technology Co Right (AFJKR) in Q2 2025, closing a stake of 750,000 shares — an estimated $270K sold.

Mangrove Partners first reported a position in AFJKR in Q1 2024 and held it in 5 quarters. The position peaked at $270K in Q1 2025. 13 funds tracked by Wall St. Rank hold AFJKR as of Q2 2025.

  • Mangrove Partners reported no remaining Aimei Health Technology Co Right position as of Q2 2025 after selling out during the quarter.
  • Mangrove Partners sold 750,000 Aimei Health Technology Co Right shares in Q2 2025, an estimated $270K.
  • Mangrove Partners first reported a position in Aimei Health Technology Co Right in Q1 2024 and held it in 5 quarters.
  • Mangrove Partners's Aimei Health Technology Co Right position peaked at $270K in Q1 2025.
  • 13 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2025.

Based on Mangrove Partners's 13F filing for Q2 2025, filed 14 Aug 2025.